Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Born too small

“The opportunity for catch-up growth is great”.

    • General Internal Medicine
    • Interviews
    • Pediatrics
    • RX
  • 2 minute read

In Switzerland, about 2500 children are born each year with a weight or height that is too small in relation to the gestational age (Small for Gestational Age). Prof. Dr. med. Urs Eiholzer from the Pediatric Endocrinology Center in Zurich explains in an interview why it is so important to check growth regularly, especially in SGA children.

Can a cause always be found when a child is very small at birth?

Prof. Urs Eiholzer, MD:
In most SGA children, growth does not slow down until the last third of pregnancy. These children are usually underweight with normal length. However, some SGA children always grow a little too little throughout pregnancy, mainly affecting body length. Reasons may include poor placental function, EPH gestosis, high blood pressure, or chronic maternal disease. In more than half of the cases, however, the reasons are unclear.

So what are the prognoses for SGA kids?
Today we know that most SGA children catch up in terms of height during the first two years of life. Especially in children who have grown insufficiently due to placental insufficiency in the last months of pregnancy, the chance for catch-up growth is great. However, approximately 9-13% of SGA children are unable to make up the shortfall and require careful monitoring. These are often those children who have suffered from malnutrition throughout pregnancy. These children are at great risk of being small as adults as well – and even smaller than growth projections suggest.

Why are so few SGA children diagnosed and treated in Switzerland?
There are several reasons for this. It is often the case that these children grow parallel to the 3rd percentile and parents and doctors simply hope that they will catch up later. Unfortunately, reality shows the opposite: SGA children who have not caught up during the first two years of life and who have not been adequately treated fall even further behind in puberty compared to their peers. Treatment with growth hormone can help not only children with a growth hormone deficiency, but also SGA children to (almost) reach their target height, even if they do not have a growth hormone deficiency. Children with SGA require higher levels of growth hormone to grow according to genetic guidelines.

Why is early diagnosis and treatment recommended?
It is critical that treatment be started as early as possible for any disorder for which growth hormone is indicated as a therapy. Then the chances are that the child will reach a normal or near normal size in adulthood.

What does the success of therapy look like for SGA children?
The goal of treatment is for the child to reach the genetically predetermined final size if possible. This goal is most likely to be achieved if treatment is started early. In SGA children, growth is enhanced by growth hormone by about 6-12 cm. However, despite treatment, these children often remain smaller than their target family size would suggest.

Interview: Susanna Steimer Miller

 

HAUSARZT PRAXIS 2015; 10(3): 44-45

Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Blood pressure
  • Body size
  • EPH gestosis
  • Growth curve
  • SGA Kids
  • Size
  • The opportunity for catch-up growth is great
Previous Article
  • Palliative Care

Mentally ill at the end of life

  • Education
  • Geriatrics
  • Prevention and health care
  • Psychiatry and psychotherapy
  • RX
View Post
Next Article
  • Prevention and treatment of ER-positive breast cancer

IBIS-1 update shows promising results

  • Congress Reports
  • Gynecology
  • Oncology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 8 min
  • Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines

In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 6 min
  • Type 1 Diabetes in Childhood

Early Impairment of Glucagon Counterregulation

    • RX
    • Education
    • Endocrinology and Diabetology
    • Pediatrics
    • Studies
View Post
  • 7 min
  • Psychosis in Parkinson's Disease

Be Careful When Choosing Medications

    • RX
    • Education
    • Geriatrics
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 3 min
  • Esophageal Cancer

A Comparison of Endoscopic and Surgical Innovations

    • RX
    • Education
    • Oncology
    • ORL
    • Studies
View Post
  • 6 min
  • PMR and LVV: Current EULAR Recommendations

Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis

    • RX
    • Angiology
    • Congress Reports
    • General Internal Medicine
    • Rheumatology
    • Studies
View Post
  • 5 min
  • Cellular and Systemic Iron Homeostasis

“Steady State” – a delicately balanced equilibrium

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Hematology
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 3 min
  • First-line treatment for T2D

SGLT2i, metformin, or both?

    • RX
    • Education
    • Endocrinology and Diabetology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Endometrial carcinoma
  • 2
    Clinical Presentation, Diagnosis, and Treatment of DSPN
  • 3
    Why is it so hard to lose weight?
  • 4
    Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
  • 5
    Functional limb preservation between infection control, vascular medicine and resurfacing

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.